- Netherlands
- /
- Medical Equipment
- /
- ENXTAM:PHIA
Is Now An Opportune Moment To Examine Koninklijke Philips N.V. (AMS:PHIA)?
Let's talk about the popular Koninklijke Philips N.V. (AMS:PHIA). The company's shares saw significant share price movement during recent months on the ENXTAM, rising to highs of €24.90 and falling to the lows of €19.50. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Koninklijke Philips' current trading price of €19.50 reflective of the actual value of the large-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Koninklijke Philips’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
What Is Koninklijke Philips Worth?
Koninklijke Philips appears to be expensive according to our price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average. We’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 78.89x is currently well-above the industry average of 30.52x, meaning that it is trading at a more expensive price relative to its peers. Furthermore, Koninklijke Philips’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. If you believe the share price should eventually reach levels around its industry peers, a low beta could suggest it is unlikely to rapidly do so anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range.
Check out our latest analysis for Koninklijke Philips
What kind of growth will Koninklijke Philips generate?
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Koninklijke Philips' earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.

What This Means For You
Are you a shareholder? It seems like the market has well and truly priced in PHIA’s positive outlook, with shares trading above industry price multiples. However, this brings up another question – is now the right time to sell? If you believe PHIA should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.
Are you a potential investor? If you’ve been keeping tabs on PHIA for some time, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the positive outlook is encouraging for PHIA, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.
In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. Our analysis shows 3 warning signs for Koninklijke Philips (2 are a bit unpleasant!) and we strongly recommend you look at these before investing.
If you are no longer interested in Koninklijke Philips, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Valuation is complex, but we're here to simplify it.
Discover if Koninklijke Philips might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ENXTAM:PHIA
Koninklijke Philips
Operates as a health technology company in North America, the Greater China, and internationally.
Good value with adequate balance sheet.
Similar Companies
Market Insights
Weekly Picks

Is this the AI replacing marketing professionals?

GameStop will ace the financial crisis wave with its strategic Bitcoin investment and cash reserves

An Undervalued 3.3Moz Gold Project in Canada
The First Real Lidar Winner
Recently Updated Narratives
Northern Solar: Explosive earnings growth makes this solar story harder to ignore

50% ROE in a Burning Building
NVIDIA will see a profit margin surge of 55% in the next 5 years
Popular Narratives
SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

